BioQ Pharma Inc — Form D
BioQ Pharma Inc of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-10. The offering totals $18.8M, of which $4.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-01-10
- Form: D
- Accession: 0001278320-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $18.8M
- Amount sold: $4.6M
- Remaining: $14.1M
- Investors: 15
- Date of first sale: 2019-12-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-357701
Issuer
- Name: BioQ Pharma Inc
- CIK: 0001278320
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 1325 HOWARD STREET, SAN FRANCISCO, CA, 94103
- Phone: 415.975.0805
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Mark J Ehlert | Director | Farmington Hills, MI |
| Norvall William Jasper, Jr. | Director | San Francisco, CA |
| Llew J Keltner | Director | San Francisco, CA |
| Joshua W Kriesel | Director | San Francisco, CA |
| Richard J Nesbit | Director | San Francisco, CA |
| Christopher J Portman | Director | San Francisco, CA |
| Daniel J Tasse | Director | San Francisco, CA |
| Joshua W Kriesel | Executive Officer | San Francisco, CA |
| Ron W Pauli | Executive Officer | San Francisco, CA |
| John W Morgan | Director | Toronto, A6 |
| Christopher A Portman | Director | San Francisco, CA |
| Marshall S Kriesel | Director | San Francisco, CA |
| Richard A Nesbit | Director | San Francisco, CA |
Other filings by this issuer (8)
More